MLA-74
chemical compound
MLA-74, also known as 1-methyllysergic acid ethylamide (1-methyl-LAE) or as 1-methyl-N-ethyllysergamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is the 1-methyl derivative of lysergic acid ethylamide (LAE-32). Extensive metabolism of other 1-methylated lysergamides to their secondary amine derivatives, for instance methysergide (1-methylmethylergometrine) conversion into methylergometrine, has been observed.
Use and effects
An active dose of MLA-74 in humans is described as being approximately 2 mg orally and the drug is said to have about 4 to 5% of the potency of LSD. It is also said to have a faster onset and shorter duration than LSD. For comparison, LAE-32 has a listed dose range of 0.5 to 1.6 mg orally, approximately 5 to 10% of the potency of LSD, and is likewise described as faster onset and shorter duration. MLA-74 is about 8-fold less potent than its analogue MLD-41 (1-methyl-LSD). Both MLA-74 and LAE-32 are described as producing LSD-like psychic effects in humans. However, they are both described as producing only slight or weak hallucinogenic effects.
Interactions
Pharmacology
Pharamcodynamics
MLA-74 shows about 8.35 times the antiserotonergic activity of LSD in the isolated rat uterus in vitro and about 70-fold the activity of LAE-32 in this assay. Unlike LAE-32, MLA-74 is practically devoid of pyretogenic effects in rabbits and is listed as having 0% of the activity of LSD in this regard.
History
MLA-74 was first described in the scientific literature by the late 1950s.
Begin with the source’s own compact description: “MLA-74” is chemical compound. The dossier treats that line as a proposition to test through MLA-74, chemical and compound, not as a finished interpretation.
Why this record matters
The phrase “chemical compound” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
The date and method of observation matter as much as the stated conclusion, especially where classification or consensus has changed. The source revision retrieved here is dated Feb 12, 2026. The linked authority identifier is Q76085038. None of the 0 selected statements returned an explicit reference.
A general summary may omit uncertainty, sample limits or methodological disagreement that is explicit in the technical record. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.
- Current terminology
- Classification context
- Finding cited technical literature
Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.
Three-step research path
- Establish the record: confirm the title “MLA-74”, its source revision and the description used here.
- Expand the search: follow MLA-74 primary sources, MLA-74 archive and MLA-74 research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “MLA-74”?
- Which observation, specimen, dataset or publication supports the account?
- Is the terminology current, historical or disputed?
Search terms from this dossier
This entry incorporates text from “MLA-74” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.